Does SECUKINUMAB Cause Blindness transient? 26 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Blindness transient have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
26
Reports of Blindness transient with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Blindness transient From SECUKINUMAB?
Of the 26 reports, 5 (19.2%) required hospitalization.
Is Blindness transient Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Blindness transient?
AFLIBERCEPT (987)
ADALIMUMAB (200)
METFORMIN (153)
DIMETHYL (119)
INTERFERON BETA-1A (102)
NATALIZUMAB (101)
RANIBIZUMAB (100)
BROLUCIZUMAB-DBLL (99)
FINGOLIMOD (89)
BEVACIZUMAB (72)
Which SECUKINUMAB Alternatives Have Lower Blindness transient Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG